India COVID-19 coronavirus by city and state
India has recorded 207,615 total confirmed cases, 5,815 deaths, 100,303 cured cases, according to the...
Read More...
Focus:
-
![Sarclisa]()
Sanofi gets EC approval for Sarclisa to treat multiple myeloma
Sanofi has received approval from the European Commission (EC) for the use of Sarclisa (isatuximab)...
Read More...
-
![Baylor College vaccine]()
Baylor College and Texas Children’s to advance Covid-19 vaccine
Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development have expanded their...
Read More...
-
![emergent biosolutions manufacturing]()
Emergent gets $628m Covid-19 vaccine manufacturing contract
Emergent BioSolutions has secured a $628m contract from the US Biomedical Advanced Research and Development...
Read More...
-
![Brilinta]()
AstraZeneca’s heart disease drug Brilinta gets FDA approval
AstraZeneca has received approval from the US Food and Drug Administration (FDA) for Brilinta (ticagrelor)...
Read More...
-
![Celltrion antibody]()
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19...
Read More...
-
![Avifavir]()
Russia grants temporary approval for Avifavir to treat Covid-19
The Ministry of Health of the Russian Federation has granted a temporary registration certificate to...
Read More...
-
![Chimeron Bio vaccine]()
Chimeron Bio and NCBID to develop Covid-19 vaccine
RNA therapeutics firm Chimeron Bio has collaborated with George Mason University’s National Center for Biodefense...
Read More...
-
![GSK adjuvant]()
GSK plans to produce one billion pandemic vaccine adjuvant doses
GlaxoSmithKline (GSK) is set to produce one billion doses of its pandemic vaccine adjuvant system...
Read More...
-
![Praha Vaccines]()
Novavax buys Praha Vaccines for Covid-19 vaccine manufacturing
Biotechnology firm Novavax has acquired Czech Republic-based Praha Vaccines for about $167m to support the...
Read More...
